[Divergence between the pharmacologic and clinical effects of inhibitors of prostaglandin synthesis].
D001241:Aspirin / Q000494:pharmacology; D001792:Blood Platelets / Q000187:drug effects; D004176:Dipyridamole / Q000494:pharmacology; D004347:Drug Interactions; D011464:Epoprostenol / Q000096:biosynthesis; D006801:Humans; D010974:Platelet Aggregation / Q000187:drug effects; D011448:Prostaglandin Antagonists / Q000494:pharmacology*; D011451:Prostaglandin-Endoperoxide Synthases / Q000378:metabolism; D012459:Salicylates / Q000494:pharmacology; D020156:Salicylic Acid; D013442:Sulfinpyrazone / Q000494:pharmacology; D013927:Thrombosis / Q000517:prevention & control; D013931:Thromboxanes / Q000096:biosynthesis
D011448:Prostaglandin Antagonists; D012459:Salicylates; D013931:Thromboxanes; D004176:Dipyridamole; D011464:Epoprostenol; D011451:Prostaglandin-Endoperoxide Synthases; D020156:Salicylic Acid; D001241:Aspirin; D013442:Sulfinpyrazone
Divergenz pharmakologischer und klinischer Wirkungen von Prostaglandinsynthesehemmern.